Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the clinical trial intelligence company and the premier provider of predictive analytics ...

A recent CII-EY HealthTech Survey reveals that Indian hospitals will boost their digital spending significantly, focusing on ...

In this Q&A, Randa Wahid of Indero, and Lyn Mursalo, a freelance clinical research professional, share how sponsors and CROs ...

Discover how Simplify Health Care ETF outperforms with active healthcare stock selection, offering alpha where others see ...

As personalised medicine continues to evolve, emerging technologies like spatialomics and AI are paving the way for ...

Stroke continues to be a leading cause of mortality and long-term disability worldwide, presenting significant challenges in prevention, acute intervention, ...

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately ...

Treace Medical Concepts, Inc. ('Treace” or the 'Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...

Reaching this stage enables safer care with fewer errors, faster diagnostics, optimised operations, and stronger patient ...

SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or ...